Clofarabine With Cytarabine for MRD Positive Leukemia.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2013
At a glance
- Drugs Clofarabine (Primary) ; Cytarabine (Primary) ; Cytarabine (Primary) ; Methotrexate
- Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 01 Oct 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 19 Aug 2010 Actual initiation date (Aug 2010) added as reported by ClinicalTrials.gov.
- 19 Aug 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.